Neuropsychopharmacology
- M6A RNA epitranscriptome dynamics linked to major depressive disorder and suicide risk1 year ago
- Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum1 year ago
- Microglia as critical mediators linking perinatal immune stress to mental health trajectories1 year ago
- A biological blind spot in addiction research: hormonal contraceptives and adolescent reward seeking1 year ago
- nNOS-expressing neurons in the mPFC mediate depression-related behaviors in mice through pPVT-mPFC projections1 year ago
- Developmental sterol biosynthesis inhibition: are prescription medications as safe as we think?1 year ago
- Distinct subpopulations of parvalbumin neurons participating in divergent prefrontal functions1 year ago
Journal of Psychopharmacology
- Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II2 years ago
- A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature2 years ago
- Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study2 years ago
- Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use3 years ago
- Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression3 years ago
- Psychiatric risks for worsened mental health after psychedelic use3 years ago
- The neural oscillations serving task switching are altered in cannabis users3 years ago
European Neuropsychopharmacology
- Editorial Board3 years ago
- Whole-brain structural and functional neuroimaging of individuals who attempted suicide and people who did not: A systematic review and exploratory coordinate-based meta-analysis3 years ago
- Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial3 years ago
- EEG abnormalities are not associated with poor antidepressant treatment outcome – A NeuroPharm study3 years ago
- Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial3 years ago
- Cognitive functioning in children and adolescents with depression: A systematic review and meta-analysis3 years ago
- Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis3 years ago